| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
¶
From the Departments of Neurology* and Molecular Microbiology and Immunology,¶ Oregon Health and Science University, Portland, Oregon; Neuroimmunology Research, Veterans Affairs Medical Center, Portland, Oregon; Veterinary Biosciences, University of Illinois, Urbana, Illinois; and the Department of Food Hygiene, Faculty of Veterinary Medicine, Warsaw Agricultural University, Warsaw, Poland
Gender influences mediated by 17ß-estradiol (E2) have been associated with susceptibility to and severity of autoimmune diseases such as diabetes, arthritis, and multiple sclerosis. In this regard, we have shown that estrogen receptor-
(Esr1) is crucial for the protective effect of 17ß-estradiol (E2) in murine experimental autoimmune encephalitis (EAE), an animal model of multiple sclerosis. The expression of estrogen receptors among various immune cells (eg, T and B lymphocytes, antigen-presenting cells) suggests that the therapeutic effect of E2 is likely mediated directly through specific receptor binding. However, the target immune cell populations responsive to E2 treatment have not been identified. In the current study, we induced EAE in T-cell-deficient, severe combined immunodeficient mice or in immunocompetent mice with encephalitogenic T cells from wild-type Esr1+/+ or Esr1 knockout (Esr1–/–) donors and compared the protective E2 responses. The results showed that E2-responsive, Esr1+/+ disease-inducing encephalitogenic T cells were neither necessary nor sufficient for E2-mediated protection from EAE. Instead, the therapeutic response appeared to be mediated through direct effects on nonlymphocytic, E2-responsive cells and down-regulation of the inflammatory response in the central nervous system. These results provide the first demonstration that the protective effect of E2 on EAE is not mediated directly through E2-responsive T cells and raise the alternative possibility that nonlymphocytic cells such as macrophages, dendritic cells, or other nonlymphocytic cells are primarily responsive to E2 treatment in EAE.
This article has been cited by other articles:
 |
|
 |
|
  F. E. Nashold, K. M. Spach, J. A. Spanier, and C. E. Hayes Estrogen Controls Vitamin D3-Mediated Resistance to Experimental Autoimmune Encephalomyelitis by Controlling Vitamin D3 Metabolism and Receptor Expression J. Immunol., September 15, 2009; 183(6): 3672 - 3681. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Sinha, L. J. Kaler, T. M. Proctor, C. Teuscher, A. A. Vandenbark, and H. Offner IL-13-Mediated Gender Difference in Susceptibility to Autoimmune Encephalomyelitis J. Immunol., February 15, 2008; 180(4): 2679 - 2685. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Vegeto, S. Belcredito, S. Ghisletti, C. Meda, S. Etteri, and A. Maggi The Endogenous Estrogen Status Regulates Microglia Reactivity in Animal Models of Neuroinflammation Endocrinology, May 1, 2006; 147(5): 2263 - 2272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. C. Lambert, E. M. Curran, B. M. Judy, G. N. Milligan, D. B. Lubahn, and D. M. Estes Estrogen Receptor {alpha} (ER{alpha}) Deficiency in Macrophages Results in Increased Stimulation of CD4+ T Cells while 17{beta}-Estradiol Acts through ER{alpha} to Increase IL-4 and GATA-3 Expression in CD4+ T Cells Independent of Antigen Presentation J. Immunol., November 1, 2005; 175(9): 5716 - 5723. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. H. van den Broek, J. G. Damoiseaux, M. H De Baets, and R. M. Hupperts The influence of sex hormones on cytokines in multiple sclerosis and experimental autoimmune encephalomyelitis: a review Multiple Sclerosis, June 1, 2005; 11(3): 349 - 359. [Abstract] [PDF]
|
|
|
|
 |
|
 M M. Elloso, K. Phiel, R. A Henderson, H. A Harris, and S. J Adelman Suppression of experimental autoimmune encephalomyelitis using estrogen receptor-selective ligands J. Endocrinol., May 1, 2005; 185(2): 243 - 252. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
